1353 studies found for:    Open Studies | "Breast Diseases"
Show Display Options
Rank Status Study
21 Recruiting IMaging PAtients for Cancer Drug selecTion - Metastatic Breast Cancer
Condition: Metastatic Breast Cancer
Intervention: Procedure: Molecular imaging
22 Recruiting Comparative Efficiency of Three Regimen, CEFci, CEF and EC as Neoadjuvant Chemotherapy for Primary Breast Cancer
Condition: Breast Cancer
Interventions: Drug: 5-FU(intravenous infusion)+epirubicin+cyclophosphamide;   Drug: 5-FU(intravenous bolus)+epirubicin+cyclophosphamide;   Drug: epirubicin+cyclophosphamide
23 Unknown  Docetaxel With or Without a Phytochemical in Treating Patients With Breast Cancer
Condition: Breast Cancer
Interventions: Dietary Supplement: phytochemical;   Drug: docetaxel;   Procedure: complementary or alternative medicine procedure
24 Recruiting Intensity Modulated Radiotherapy (IMRT) vs. 3D-conformal Accelerated Partial Breast Irradiation (APBI) for Early Stage Breast Cancer After Lumpectomy
Condition: Breast Cancer
Interventions: Radiation: accelerated partial breast irradiation - 3D-conformal planning;   Radiation: accelerated partial breast irradiation - IMRT planning
25 Recruiting Promoting Breast Cancer Screening in Non-adherent Women
Condition: Breast Cancer
Interventions: Behavioral: Reminder Letter;   Behavioral: Reminder Call;   Behavioral: Counselor Call
26 Recruiting Using Bio Markers to Predict Disease Recurrence and Cognitive Function in High Risk Breast Ca
Conditions: Locally Advanced Breast Cancer;   Breast Cancer
Intervention:
27 Not yet recruiting Photoacoustic Imaging (PAI) of Suspicious Breast Cancers - A Clinical Feasibility Study
Condition: Breast Cancer
Intervention: Procedure: Photoacoustic Imaging (PAI)
28 Recruiting The Impact of a Physical Activity Program on Biomarkers of Aging During Chemotherapy for Breast Cancer
Conditions: Breast Cancer;   Aging
Intervention: Behavioral: Walk With Ease
29 Unknown  Evaluation of Maxy-G34 in Breast Cancer Patients Treated With TAC (Docetaxel, Adriamycin, Cyclophosphamide) Chemotherapy
Conditions: Chemotherapy-Induced Neutropenia;   Breast Cancer
Intervention: Biological: Maxy-G34
30 Recruiting Brain Functional MRI in Older Women With Breast Cancer (Brain fMRI-BC)
Condition: Breast Cancer
Intervention:
31 Unknown  A Phase I Cancer Vaccine Study for Patients With Metastatic Breast Cancer
Condition: Metastatic Breast Cancer
Intervention: Biological: Dendritic Cell Vaccination
32 Recruiting Sentinel Node Biopsy in Breast Cancner: Omission of Axillary Clearance After Micrometastasis
Condition: Breast Cancer
Intervention: Procedure: Omission of axillary clearance
33 Recruiting CC-486 (Oral Azacitidine) Bioequivalence Study in Patients With Solid Tumor or Hematologic Malignancies
Conditions: Hematological Neoplasms;   Non-Hodgkin's Lymphoma;   Hodgkin's Lymphoma;   Lymphoma;   Multiple Myeloma;   Acute Myeloid Leukemia;   Leukemia;   Myelodysplastic Syndromes;   Neoplasms;   Melanoma;   Breast Cancer;   Metastatic Breast Cancer;   Non-Small Cell Lung Cancer;   Small Cell Lung Cancer;   Renal Cell Carcinoma;   Glioblastoma Multiforme;   Osteosarcoma;   Sarcoma;   Thyroid Cancer;   Genitourinary
Interventions: Drug: CC-486;   Drug: Vidaza
34 Recruiting Pharmacokinetically Guided Everolimus in Patients With Breast Cancer, Pancreatic Neuroendocrine Tumors, or Kidney Cancer
Conditions: Estrogen Receptor-positive Breast Cancer;   Gastrinoma;   Glucagonoma;   HER2-negative Breast Cancer;   Insulinoma;   Mucositis;   Oral Complications;   Pancreatic Polypeptide Tumor;   Progesterone Receptor-positive Breast Cancer;   Recurrent Breast Cancer;   Recurrent Islet Cell Carcinoma;   Recurrent Renal Cell Cancer;   Somatostatinoma;   Stage III Renal Cell Cancer;   Stage IIIA Breast Cancer;   Stage IIIB Breast Cancer;   Stage IIIC Breast Cancer;   Stage IV Breast Cancer;   Stage IV Renal Cell Cancer
Intervention: Drug: everolimus
35 Recruiting Fulvestrant +/- Akt Inhibition in Advanced Aromatase Inhibitor Resistant Breast Cancer
Condition: Estrogen Receptor Positive Breast Cancer
Interventions: Drug: AZD5363;   Drug: Placebo;   Drug: Fulvestrant
36 Recruiting Pharmacogenomic Study of Neoadjuvant Eribulin for HER2 Non-overexpressing Breast Cancer
Condition: Breast Cancer
Intervention: Drug: Eribulin
37 Recruiting Study of Concurrent Paclitaxel and Radiation: Correlation of Tumor Profiles With Pathologic Response
Condition: Breast Cancer
Interventions: Drug: Paclitaxel;   Radiation: Radiation therapy
38 Recruiting A Prospective, Randomized Multicenter, Open-label Comparison of Preoperative Combination of Trastuzumab and Pertuzumab With or Without Concurrent Taxane Chemotherapy Given for Twelve Weeks in Patients With Operable HER2+/HR- Breast Cancer Within the ADAPT Protocol
Condition: Breast Cancer
Interventions: Drug: Trastuzumab;   Drug: Pertuzumab;   Drug: Paclitaxel
39 Not yet recruiting Neoadjuvant Trial of Capecitabine for Axillary Lymph Node Positive Operable Breast Cancer
Conditions: Stage II Breast Cancer;   Stage III Breast Cancer
Interventions: Drug: fluorouracil;   Drug: capecitabine;   Drug: cyclophosphamide;   Drug: Epirubicin
40 Recruiting Johns Hopkins Breast Cancer Program Hormone Therapy Longitudinal Database
Condition: Breast Cancer
Interventions: Other: Sample collection;   Behavioral: Patient-reported outcomes

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years